CN Patent

CN104761546A — 一种新颖的 (1s)-1,5-脱氢-1-[3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基]-d-葡萄糖醇晶型及其制备方法

Assigned to Shandong Fu Chuan Pharmaceutical Technology Co Ltd · Expires 2015-07-08 · 11y expired

What this patent protects

本发明提供一种新颖的(1S)-1,5-脱氢-1-[3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基]-D-葡萄糖醇晶型，（简称：卡格列净β晶型），该晶型稳定性好，适宜规模化生产，本发明还提供了该晶型的制备方法。

USPTO Abstract

本发明提供一种新颖的(1S)-1,5-脱氢-1-[3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基]-D-葡萄糖醇晶型，（简称：卡格列净β晶型），该晶型稳定性好，适宜规模化生产，本发明还提供了该晶型的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104761546A
Jurisdiction
CN
Classification
—
Expires
2015-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Fu Chuan Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.